Deshmukh Tejas, Kovoor Joshua G, Byth Karen, Chow Clara K, Zaman Sarah, Chong James J H, Figtree Gemma A, Thiagalingam Aravinda, Kovoor Pramesh
Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia.
Centre for Heart Research, Westmead Institute for Medical Research, University of Sydney, Westmead, Sydney, NSW, Australia.
Front Cardiovasc Med. 2023 Oct 24;10:1283382. doi: 10.3389/fcvm.2023.1283382. eCollection 2023.
Inducible ventricular tachycardia (VT) at electrophysiology study (EPS) predicts sudden cardiac death because of ventricular tachyarrhythmia, the single greatest cause of death within 2 years after myocardial infarction (MI).
We aimed to assess the association between standard modifiable risk factors (SMuRFs) and inducible VT at EPS early after MI.
Consecutive patients with left ventricle ejection fraction ≤40% on days 3-5 after ST elevation MI (STEMI) who underwent EPS were prospectively recruited. Positive EPS was defined as induced sustained monomorphic VT cycle length ≥200 ms for ≥10 s or shorter if hemodynamically compromised. The primary outcome was inducibility of VT at EPS, and the secondary outcome was all-cause mortality on follow-up.
In 410 eligible patients undergoing EPS soon (median of 9 days) after STEMI, 126 had inducible VT. Ex-smokers experienced an increased risk of inducible VT [multivariable logistic regression adjusted odds ratio (OR) 2.0, = 0.033] compared with current or never-smokers, with comparable risk. The presence of any SMuRFs apart from being a current smoker conferred an increased risk of inducible VT (adjusted OR 1.9, = 0.043). Neither the number of SMuRFs nor the presence of any SMuRFs was associated with mortality at a median follow-up of 5.4 years.
In patients with recent STEMI and impaired left ventricular function, the presence of any SMuRFs, apart from being a current smoker, conferred an increased risk of inducible VT at EPS. These results highlight the need to modify SMuRFs in this high-risk subset of patients.
电生理检查(EPS)时可诱发的室性心动过速(VT)可预测因室性快速性心律失常导致的心脏性猝死,而室性快速性心律失常是心肌梗死(MI)后2年内的单一最大死因。
我们旨在评估标准可改变危险因素(SMuRFs)与MI后早期EPS时可诱发VT之间的关联。
前瞻性招募ST段抬高型心肌梗死(STEMI)后3至5天左心室射血分数≤40%且接受EPS的连续患者。EPS阳性定义为诱发持续单形性VT,周长≥200毫秒且持续≥10秒,若血流动力学不稳定则持续时间更短。主要结局是EPS时VT的可诱发性,次要结局是随访时的全因死亡率。
在410例STEMI后不久(中位时间9天)接受EPS的符合条件患者中,126例可诱发VT。与当前吸烟者或从不吸烟者相比,既往吸烟者发生可诱发VT的风险增加[多变量逻辑回归调整优势比(OR)为2.0,P = 0.033],风险相当。除当前吸烟者外,存在任何SMuRFs均会增加可诱发VT的风险(调整后OR为1.9,P = 0.043)。在中位随访5.4年时,SMuRFs的数量或任何SMuRFs的存在均与死亡率无关。
在近期STEMI且左心室功能受损的患者中,除当前吸烟者外,存在任何SMuRFs均会增加EPS时可诱发VT的风险。这些结果凸显了在这一高危患者亚组中改变SMuRFs的必要性。